Thomas Fleischer, project leader at Institute for Cancer Research (ICR), Oslo University Hospital, has been awarded the Researcher of the Year 2025 prize by the ICR leadership.
The prize was presented at the Institute seminar on December 17 and includes a personal scholarship of 100,000 NOK funded by the Radium Hospital Foundation to support further research excellence.
Yanjiao Li, researcher form the Department of Microbiology at Oslo University Hospital and CRESCO Centre for embryology and healthy development (UiO), has received 10 million Norwegian kroner in FRIPRO funding from the Research Council of Norway. FRIPRO is awarded for frontier research with the potential to push the boundaries of knowledge.
One in six people experiences infertility. Assisted reproductive technologies (ARTs)-babies now account for 6% of all newborns. Although in vitro fertilization (IVF) helps many, it still fails often. Only about half of the fertilized eggs grow into blastocysts, the stage where they are implanted in the uterus. Not every transferred embryo results in pregnancy.
Srdjan Djurovic recieves 40 millioner NOK from the Top Researchers program (Toppforsk) hosted by The Research Council of Norway to find out if it is possible to predict Alzheimer disease at an early stage. The supported project is entitled "Multimodal metabolic markers for mechanisms and predictive trajectories of Alzheimer's disease".
This disease starts long before the symptoms appear, often several decades earlier. Djurovic and his research group will “go back in time” and analyze blood samples from people in their 40s and 50s to find hereditary metabolic markers that can warn of risk.
Recommended sites for current research articles:
From Oslo University Hospital, in Norwegian:
OUS Innsikt – ny forskning, innovasjon og behandling - channel for science communication
More news from OUS (oslo-universitetssykehus.no)
From centres of excellence (UiO/OUS):
CanCell - Centre for Cancer Cell Reprogramming
Cresco - Centre for Embryology and Healthy Development
PRIMA - Precision Immunotherapy Alliance - Norwegian version
Hybrid Technology Hub - Centre for Organ on a Chip-Technology
For the second year in a row, Inven2, in collaboration with Oslo University Hospital (OUS), has conducted an innovation campaign to highlight research-based ideas with commercial potential from OUS. In this year's competition, Beata Grallert from the Institute of Cancer Research came out on top. Her project, which investigates the regulation of cell division, impressed the jury with the groundbreaking new regulatory mechanism she discovered. This opens up completely new possibilities for the treatment of cancer.
SISAQOL-IMI (Setting International Standards of Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials) is pleased to announce the publication of a central article in The Lancet Oncology, along with the release of a number of useful tools.
Oslo University Hospital HF has been an active partner in the consortium, and leading work package 7, which was responsible for the consensus process and the final project deliverables. OUS co-authors on the SISAQOL-IMI publication are Cecilie Delphin Amdal (first author), Ragnhild Falk, Kenth-Louis Hansen Joseph and Kristin Bjordal (joint last author) .
In order to stimulate excellent research and draw attention to the hospital's research activity, Oslo University Hospital rewards outstanding publications twice a year. Six research groups were awarded for their excellent papers published the first half-year of 2025 during a ceremony on December 3rd. Each group received NOK 50.000 earmarked for further research, and the prize winners gave short presentations of their findings.
The awards for outstanding research articles are distributed twice a year based on more than 2,400 scientific articles published annually by OUS. The division's research committees nominate the articles and an external committee evaluates and finally selects the six worthy winners.
Have you ever experienced hearing the voice of a grandmother or grandfather who has recently died, and perceived the voice as real?
Experiences like these are more common than you might think. As many as 10–17% report so-called psychosis-like experiences during their lifetime.
In her doctoral thesis, Viktoria Birkenæs found that 30% of 22,000 Norwegian adolescents reported psychosis-like experiences. Although the vast majority did not develop a psychiatric disorder, those who reported these experiences had a higher risk of receiving a diagnosis of mental illness.
"We have finally found a good alternative for pain relief right at the start, when it can be difficult to give painkillers through a needle", say the researchers behind the PreMeFen study, which was recently published in the prestigious journal The Lancet.
The study is led by Fridtjof Heyerdahl, a senior researcher at SNLA, OUS and UiO, and head of the Air Ambulance Department at OUS. The study's first author is Randi Simensen, a research fellow at SNLA and Innlandet Hospital.
One patient group received the medication methoxyflurane, which was inhaled through a pipe. The other group received a nasal spray with the medication fentanyl. The last group of patients received morphine via a needle in a vein, which is the treatment that has been used for several decades. The PreMeFen study is the first randomized controlled trial in the world to compare these three treatment options. And it is being done in the ambulance service, where the patients are.
